Towards optimal cut-off trough levels of adalimumab and etanercept for a good therapeutic response in rheumatoid arthritis. Results of the INMUNOREMAR study
- PMID: 25805737
- DOI: 10.1136/annrheumdis-2015-207530
Towards optimal cut-off trough levels of adalimumab and etanercept for a good therapeutic response in rheumatoid arthritis. Results of the INMUNOREMAR study
Keywords: DAS28; Rheumatoid Arthritis; Treatment.
Comment in
-
Response to: 'Towards optimal cut-off trough levels of adalimumab and etanercept for a good therapeutic response in rheumatoid arthritis. Results of the INMUNOREMAR study' by Sanmarti et al.Ann Rheum Dis. 2015 Aug;74(8):e43. doi: 10.1136/annrheumdis-2015-207543. Epub 2015 Apr 3. Ann Rheum Dis. 2015. PMID: 25841164 No abstract available.
Comment on
-
Significant associations of antidrug antibody levels with serum drug trough levels and therapeutic response of adalimumab and etanercept treatment in rheumatoid arthritis.Ann Rheum Dis. 2015 Mar;74(3):e16. doi: 10.1136/annrheumdis-2013-203893. Epub 2014 Jan 17. Ann Rheum Dis. 2015. PMID: 24442879
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical